Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
NCT05269134 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2023-11-30
Summary
This is a study designed to evaluate bacteriophage therapy in patients with chronic prosthetic joint infections.
Conditions
- Prosthetic Joint Infection
Interventions
- DRUG
-
Bacteriophage
Phage Therapy
- DRUG
-
Placebo
Sponsors & Collaborators
-
Adaptive Phage Therapeutics, Inc.
lead INDUSTRY
Principal Investigators
-
Edward Fang, MD · Adaptive Phage Therapeutics, Chief Medical Officer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-27
- Primary Completion
- 2025-07-31
- Completion
- 2027-07-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Rifampin-combined Antibiotic Therapy for Staphylococcal PJI
NCT07313215 ·Status: RECRUITING ·Phase: NA
-
NGS vs Culture Outcomes for Treatment of PJI
NCT05247281 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas Aeruginosa
NCT06798168 ·Status: AVAILABLE
-
Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
NCT01144000 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections
NCT06089044 ·Status: COMPLETED
-
Or v IV Antibiotics for Infection
NCT04723940 ·Status: UNKNOWN ·Phase: PHASE3
-
Phage Safety Cohort Study
NCT04650607 ·Status: RECRUITING
-
Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR
NCT04672525 ·Status: RECRUITING ·Phase: PHASE3
-
Short Against Long Antibiotic Therapy for Infected Orthopedic Sites
NCT05499481 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis
NCT03091439 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection
NCT01757236 ·Status: UNKNOWN ·Phase: PHASE2
-
Subcutaneous Suppressive Antibiotic Therapy for Bone and Joint Infections
NCT03403608 ·Status: COMPLETED
-
Short Post-surgical Antibiotic Therapy in Spine Infections - a Prospective, Randomized, Unblinded, Non-inferiority Trial
NCT04048304 ·Status: RECRUITING ·Phase: NA
-
Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia
NCT03163446 ·Status: COMPLETED ·Phase: PHASE2
-
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
NCT05502380 ·Status: RECRUITING ·Phase: PHASE3
-
Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections
NCT02569541 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci
NCT00428844 ·Status: COMPLETED ·Phase: PHASE2
-
Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital
NCT05239312 ·Status: UNKNOWN
-
Tedizolid Prolonged Treatment for Prosthetic Joint Infections
NCT03378427 ·Status: COMPLETED ·Phase: NA
-
Pilot Evaluation of Two Test Materials With a Positive Control When Used as a Patient Preoperative Skin Preparation
NCT03861780 ·Status: COMPLETED ·Phase: PHASE3
-
Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty
NCT04075526 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Relevance of Intracellular Staphylococci in BOne and Joint Infections
NCT04625478 ·Status: COMPLETED
-
Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites
NCT02436876 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Two Empirical Antimicrobial Therapies of Prosthetic Joint Infection
NCT03850860 ·Status: COMPLETED
-
Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center
NCT03209934 ·Status: COMPLETED